need to just consider the facts

it is in times like this that one needs to just consider the facts and not the circumstances that we find the stock in at this moment in time. The market cap of $NRXP is around $400 million currently. If we get an EUA and sell a million doses (I think rather quickly probably) that will generate 7 or 8 or 9 or 10 billion dollars in gross sales divided by two and subtrating the costs of these sales should result "still" in 2 or 3 billion in profits for RLFTF and this company each. Multiply that times your forward earnings and certainly we could see a 5 to 10 billion dollar value easily, maybe more. I hope this back of a matchbox accountting has been helpful. That's only for the IV therapeutic, the inhaler adds more value, as does all the other possibilities which "intelligent" people will also see. Be careful, don't sell this stock quickly because you have had a "fright!" I've been in your shoes and I have regretted selling too fast in the past. $NRX Pharmaceuticals Inc.(NRXP)$